Activated factor VIII as a therapeutic agent and method of treat

Details Activated factor VIII as a therapeutic agent and method of treat Activated factor VIII as a therapeutic agent and method of treat

1993-09-13

1996-11-19

Fleisher, Mindy

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, 514802, 514834, 530381, 530383, 530830, A61K 3836, A61K 3837, C07K 14745, C07K 14755

Patent

active

055762913

ABSTRACT:
Stabilized and activated Factor VIII is used as a therapeutic agent to treat patients with a Factor VIII deficiency. This includes hemophilia A patients as well as patients with Factor VIII inhibitors which block the hemostatic activity of Factor VIII. The stabilized and activated Factor VIII is also prepared in a therapeutic composition with a therapeutically acceptable adjuvant.

REFERENCES:
patent: 4386068 (1983-05-01), Mitra et al.
patent: 4387092 (1983-06-01), Liautaud et al.
patent: 4404131 (1983-09-01), Schwarz et al.
patent: 4508709 (1985-04-01), Amphlett et al.
patent: 4649132 (1987-03-01), Zimmerman et al.
patent: 4757006 (1988-07-01), Toole, Jr. et al.
patent: 4758657 (1988-07-01), Farb et al.
patent: 4769336 (1988-09-01), Zimmerman et al.
patent: 4795806 (1989-01-01), Brown et al.
patent: 4831119 (1989-05-01), Nordfang et al.
patent: 4857635 (1989-08-01), Zimmerman et al.
patent: 4868112 (1989-09-01), Toole, Jr.
patent: 4877614 (1989-10-01), Andersson et al.
patent: 4965199 (1990-10-01), Capon et al.
patent: 4980456 (1990-12-01), Scandella et al.
patent: 4981951 (1991-01-01), Tsay
patent: 5101016 (1992-03-01), Zimmerman et al.
patent: 5149687 (1992-09-01), Scandella et al.
patent: 5171844 (1992-12-01), van Ooyen et al.
Pittman et al. A2 Domain of Human Recombinant-Derived Factor VIII etc. Blood, vol. 79, No. 2, pp. 389-397, Jan. 15, 1992.
Scandella et al. Human Factor VIII Inhibitors: Further Epitope etc., Thrombosis Haemostasis, vol. 58, Issue 1, p. 520, 1987.
Curtis et al. Characterization of a Stable Preparation of Thrombin--etc., American Society of Hematology Meeting, Anaheim, California, Dec. 8, 1992.
Tuddenham et al. The Properties of Factor VIII Coagulant Activity etc., The C. V. Mosby Company, J. Lab. Clin. Med. vol. 93, No. 1, pp. 40-53, Jan. 1979.
Weinstein et al. Analysis of Factor VIII Coagulant Antigen etc., Proc. Natl. Acad. Sci. USA, vol. 78, No. 8, pp. 5137-5141, Aug. 1981.
Vehar et al. Structure of Human Factor VIII Nature vol. 312, pp. 337-342, Nov. 22, 1984.
Fulcher et al. Localization of Human Factor VIII Inhibitor etc. Proc. Natl. Acad. Sci. USA, vol. 82, pp. 7728-7732, Nov. 1985.
Brinkhous et al. Purified Human Factor VIII Procoagulant Protein etc. Proc. Natl. Acad. Sci. USA, vol. 82, pp. 8752-8756, Dec. 1985.
Eaton et al. Construction and Characterization of an Active Factor etc. Biochemistry, vol. 25, No. 26, pp. 8343-8346, Dec. 30, 1986.
Eaton et al. Characterization of Recombinant Human Factor VIII The J. of Biological Chemistry, vol. 262, No. 7, pp. 2385-3290, Mar. 5, 1987.
Nordfang et al. FVIII Subunits: Purification and Antigenic Properties Thrombosis and Haemostasis 58 (4) 1043-1048, 1987.
Scandella et al. Epitope Mapping of Human Factor VIII Inhibitor etc. Proc. Natl. Acad. Sci. USA, vol. 85, pp. 6152-6156, Aug. 1988.
Lollar et al. Subunit Structure of Thrombin-Activated Porcine etc. Biochemistry 1989, 28, 666-674.
White et al. Factor VIII Gene and Hemophilia A Blood Reviews (1989) 3, 180-191; Blood vol. 73, No. 1, pp. 1-12, Jan. 1989.
Bihoreau et al. Isolation and Characterization of Different etc. Eur. J. Biochem. 185, 111-118 (1989) Feb.
Scandella et al. Localization of Epitopes for Human Factor VIII etc. Blood, vol. 74, No. 5, Oct. 1989, pp. 1618-1626.
Tuddenham, Factor VIII and Haemophilia A Bailliere's Clinical Haematology, vol. 2, No. 4, Oct. 1989, pp. 849-877.
Kaufman, Genetic Engineering of Factor VIII Nature vol. 342, 9 Nov. 1989, pp. 207-208.
Nordfang, Coagulation Factor VIII European J. of Haematology, Supplementum No. 49, vol. 43, 1989.
Lollar et al. PH-Dependent Denaturation of Thrombin-Activated etc. The J. of Biological Chemistry, vol. 265, No. 3, pp. 1688-1692, Jan. 25, 1990.
Foster et al. Synthetic Factor VIII Peptides With Amino Acid etc. Blood, vol. 75, No. 10, pp. 1999-2004, May 15, 1990.
Kemball-Cook et al. Factor VIII Heavy Chain Polypeptides in Plasma etc. British Journal of Haematology, 1990, 76, 80-87.
Foster et al. A Synthetic Factor VIII Peptide of Eight Amino Acid etc. Thrombosis and Haemostasis, 63 (3) 403-406 (1990).
Krishnan et al. Thrombin Cleavage Analysis of a Novel etc. Eur. J. Biochem. 195, pp. 637-644 (Received 1990) Feb. 1991.
Ingerslev et al. Clinical Experience with Hemofil M in a Hemophilia etc. Ann. Hematol (1991) 63:52-154.
Fay et al. Human Factor VIIIA Subunit Structure Reconstitution etc. The J. of Biological Chemistry vol. 266, No. 14, pp. 8957-8962, May 15, 1991.
Lollar et al. Structural Basis for the Decreased Procoagulant etc. The J. of Biological Chemistry vol. 266, No. 19, pp. 12481-12486, Jul. 5, 1991.
Fay et al. Characterization of the Interaction Between the A2 Subunit etc. The J. of Biological Chemistry vol. 267, No. 19, pp. 13246-13250, Jul. 5, 1992.
Foster et al. Factor VIII Structure and Function Blood Reviews (1989) 3, 180-191; 1989 Longman Group UK Ltd.
Curtis J. E., et al. Structural Studies of Human Factor VIII etc.
The Journal of Biological Chem. vol. 269, No. 8, 25 Feb. 1994, Baltimore USA, pp. 6246-6251, Curtis et al Isolation & Characterization of Thrombin-Activated Human Factor VIII.
Curtis et al Am. Soc. Hemat. (ASH) #1457 (HbSt) Dec. 1992.
Fay et al J. Biol. Chem. vol. 266 No. 14 (May 1991) pp. 8857-8862.
Fay et al J. Biol. Chem. vol. 267, No. 19 (Jul. 1992) pp. 13246-13250.

Affiliated with

Also associated with

Rating

Activated factor VIII as a therapeutic agent and method of treat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Activated factor VIII as a therapeutic agent and method of treat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activated factor VIII as a therapeutic agent and method of treat will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-541006